IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome
Top Cited Papers
Open Access
- 7 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Pediatric Nephrology
- Vol. 35 (8), 1529-1561
- https://doi.org/10.1007/s00467-020-04519-1
Abstract
Idiopathic nephrotic syndrome newly affects 1–3 per 100,000 children per year. Approximately 85% of cases show complete remission of proteinuria following glucocorticoid treatment. Patients who do not achieve complete remission within 4–6 weeks of glucocorticoid treatment have steroid-resistant nephrotic syndrome (SRNS). In 10–30% of steroid-resistant patients, mutations in podocyte-associated genes can be detected, whereas an undefined circulating factor of immune origin is assumed in the remaining ones. Diagnosis and management of SRNS is a great challenge due to its heterogeneous etiology, frequent lack of remission by further immunosuppressive treatment, and severe complications including the development of end-stage kidney disease and recurrence after renal transplantation. A team of experts including pediatric nephrologists and renal geneticists from the International Pediatric Nephrology Association (IPNA), a renal pathologist, and an adult nephrologist have now developed comprehensive clinical practice recommendations on the diagnosis and management of SRNS in children. The team performed a systematic literature review on 9 clinically relevant PICO (Patient or Population covered, Intervention, Comparator, Outcome) questions, formulated recommendations and formally graded them at a consensus meeting, with input from patient representatives and a dietician acting as external advisors and a voting panel of pediatric nephrologists. Research recommendations are also given.Keywords
Funding Information
- The International Pediatric Nephrology Association
This publication has 214 references indexed in Scilit:
- Rituximab in Children with Resistant Idiopathic Nephrotic SyndromeJournal of the American Society of Nephrology, 2012
- Clinical trial of focal segmental glomerulosclerosis in children and young adultsKidney International, 2011
- Nephrotic syndrome in The Netherlands: a population-based cohort study and a review of the literaturePediatric Nephrology, 2011
- Efficacy and Safety of Treatment with Rituximab for Difficult Steroid-Resistant and -Dependent Nephrotic SyndromeClinical Journal of the American Society of Nephrology, 2010
- Immunosuppression and Renal Outcome in Congenital and Pediatric Steroid-Resistant Nephrotic SyndromeClinical Journal of the American Society of Nephrology, 2010
- Risk Factors for Cyclosporin A Nephrotoxicity in Children with Steroid-Dependant Nephrotic SyndromeClinical Journal of the American Society of Nephrology, 2009
- Treatment of Severe Edema in Children with Nephrotic Syndrome with Diuretics Alone — A Prospective StudyClinical Journal of the American Society of Nephrology, 2009
- Cyclosporin A is superior to cyclophosphamide in children with steroid-resistant nephrotic syndrome—a randomized controlled multicentre trial by the Arbeitsgemeinschaft für Pädiatrische NephrologiePediatric Nephrology, 2008
- Recurrence of steroid-resistant nephrotic syndrome in kidney transplants is associated with increased acute renal failure and acute rejectionKidney International, 1994
- INCIDENCE, TREATMENT, AND OUTCOME OF RECURRENT FOCAL SEGMENTAL GLOMERULOSCLEROSIS POSTTRANSPLANTATION IN 42 ALLOGRAFTS IN CHILDRENTransplantation, 1991